PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-0.35%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
0.52%
Positive gross profit growth while NXPI is negative. John Neff would see a clear operational edge over the competitor.
-16.03%
Negative EBIT growth while NXPI is at 870.52%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-5.08%
Negative operating income growth while NXPI is at 870.52%. Joel Greenblatt would press for urgent turnaround measures.
-4.78%
Negative net income growth while NXPI stands at 919.53%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-4.81%
Negative EPS growth while NXPI is at 921.05%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-4.90%
Negative diluted EPS growth while NXPI is at 924.32%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.20%
Share reduction more than 1.5x NXPI's 0.49%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.10%
Diluted share count expanding well above NXPI's 0.14%. Michael Burry would fear significant dilution to existing owners' stakes.
-0.00%
Dividend reduction while NXPI stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-42.68%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-47.69%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
54.04%
10Y revenue/share CAGR at 50-75% of NXPI's 101.53%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
24.84%
5Y revenue/share CAGR under 50% of NXPI's 66.65%. Michael Burry would suspect a significant competitive gap or product weakness.
23.53%
3Y revenue/share CAGR at 75-90% of NXPI's 29.39%. Bill Ackman would expect new product strategies to close the gap.
107.34%
10Y OCF/share CAGR at 50-75% of NXPI's 208.67%. Martin Whitman might fear a structural deficiency in operational efficiency.
102.79%
Below 50% of NXPI's 374.98%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
86.39%
3Y OCF/share CAGR 1.25-1.5x NXPI's 66.94%. Bruce Berkowitz might see if strategic cost controls or product mix drove recent gains.
179.18%
Net income/share CAGR at 50-75% of NXPI's 244.22%. Martin Whitman might question if the firm’s product or cost base lags behind.
330.89%
Below 50% of NXPI's 4108.33%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
121.75%
Below 50% of NXPI's 765.10%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
36.24%
Equity/share CAGR of 36.24% while NXPI is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
10.06%
Below 50% of NXPI's 681.91%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
8.51%
Below 50% of NXPI's 782.23%. Michael Burry suspects a serious short-term disadvantage in building book value.
1145.59%
Dividend/share CAGR of 1145.59% while NXPI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
193.66%
Dividend/share CAGR of 193.66% while NXPI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
66.64%
3Y dividend/share CAGR of 66.64% while NXPI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
5.52%
Our AR growth while NXPI is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
2.96%
Inventory growth well above NXPI's 2.79%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-2.76%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
1.38%
Under 50% of NXPI's 16.74%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-6.95%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
7.58%
R&D growth drastically higher vs. NXPI's 1.38%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
6.81%
We expand SG&A while NXPI cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.